• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Earnings

'Normal' Market Selloff Feels Much Worse Than It Really Is

While painful to longs, the market will be better for it.
By JAMES "REV SHARK" DEPORRE
Jan 30, 2018 Updated Jan 30, 2018 | 11:34 AM EST
Stocks quotes in this article: IOVA, IMMR, LRCX, MARK, CMCM

The market is experiencing some real selling for the first time in a very long time. This isn't a particularly unusual bout of profit-taking but it has been so long since we have seen "normal" selling it feels much worse than it really is.

The big shift this morning was that the dip buyers were thrashed and instead of a quick recovery, the indices have taken out the early lows and we are seeing a lower low. That has been very rare to see. As I've written often, the bears have been terrible at generating downside momentum but they finally have a little bit going today.

At this point I believe this is still very healthy corrective action that is long overdue. We have to shake up market players a bit and reduce the high level of complacency that has been building. Perhaps this is the start of a topping process but I'm not yet convinced that we have seen the highs.

I'm looking for some new buys into this weakness but am not moving too quickly so far. My Stock of the Week, Iovance Biotherapeutics (IOVA) is acting like a champ and Immersion Corp. (IMMR) , which I discussed yesterday, is up nicely as well.

I want to buy some dips but am doing so incrementally. I stuck a toe in Lam Research (LRCX) and am eyeing other names such as Remark Holdings (MARK) , Cheetah Mobile (CMCM) and some biotechnology names but haven't made any significant additions so far.

This action is painful if you have long positions but it is badly needed and the market will be better for it. Manage those positions and try to keep losses contained.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long IOVA, IMMR, MARK and CMCM.

TAGS: Investing | U.S. Equity | Earnings | Markets | How-to | Stocks

More from Earnings

Is It Time to Jump Back Into Ford? Here's How to Trade It

Stephen Guilfoyle
May 16, 2022 11:00 AM EDT

I do believe that the risk/reward proposition is starting to think about smiling favorably on Ford.

Markets, Not So Confident Fed, Stocks Losing Streak, China Economy, My Trades

Stephen Guilfoyle
May 16, 2022 7:18 AM EDT

This week's earnings focus will be on the retailers with rivals such as Walmart and Target, as well as Home Depot and Lowe's reporting.

10 'Benjamin Graham Defensive' Stocks Make That Make the Grade

Jonathan Heller
May 13, 2022 12:00 PM EDT

This is the largest list of qualifiers since the pandemic began.

Affirm's Results Impressed and Here's Why I Want a Piece of the Action

Stephen Guilfoyle
May 13, 2022 11:00 AM EDT

There are several reasons why the shares were trading higher.

Affirm's Bounce Fails to Impress Me

Bruce Kamich
May 13, 2022 8:45 AM EDT

Don't expect AFRM to rally for long or go very far.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:14 PM EDT PAUL PRICE

    A New, Very Scary Movie

  • 08:51 AM EDT PAUL PRICE

    Advice From the Future...

  • 12:20 PM EDT PAUL PRICE

    A Blast From the Past Regarding Bitcoin

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login